Skip to main content

15 April 2026

Last updated: Wednesday 8 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Royalty and revenue financing: Paul Capital explains

Tuesday 10 June 2008

Interviewee/Contributor

Ken McLeod

Organisation

Paul Capital Healthcare

Organisations

BioLizard NV
Forbion Capital Partners BV
KEMRI Wellcome Trust Research Programme
Roche Group
Purespring Therapeutics Ltd
Alliance for Regenerative Medicine
Ariceum Therapeutics GmbH
AstraZeneca Plc and Emulate Inc
Yorkville Advisors
Merlin Biosciences Ltd

Interviewees and Contributers

Hugh Laverty
Rein Strijker
Katherine Smith
Dominique Costantini
Michael L Roberts
Max Hasmann
Nigel Davis
Khalid Ishaque
Iain Wilcock
Jens Bager

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

Commit Biologics names biotech entrepreneur as CEO

Saturday 14 March 2026

Orexo changes management in strategic shift

Saturday 14 March 2026

New CFO at Beacon Therapeutics

Saturday 14 March 2026

4basebio names new COO and CCO, strengthens commercial team

Saturday 14 March 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form